These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Lymphangioleiomyomatosis: a rare cause of breathlessness. Vinodh BN; Sharma SK; Mukhopadhyay S; Gupta SD Indian J Chest Dis Allied Sci; 2004; 46(3):205-8. PubMed ID: 15553209 [TBL] [Abstract][Full Text] [Related]
9. Examining heterogeneity in phase II trial designs may improve success in phase III. Tuma RS J Natl Cancer Inst; 2008 Feb; 100(3):164-6. PubMed ID: 18230788 [No Abstract] [Full Text] [Related]
10. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis. Suman VJ; Dueck A; Sargent DJ Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764 [No Abstract] [Full Text] [Related]
11. [Quantitative bibliographic analysis of French clinical research in the treatment of bronchopulmonary cancer]. Lebeau B Rev Mal Respir; 1998 Apr; 15(2):185-9. PubMed ID: 9608989 [TBL] [Abstract][Full Text] [Related]
12. Treatment option(s) for pulmonary lymphangioleiomyomatosis: progress and current challenges. Krymskaya VP Am J Respir Cell Mol Biol; 2012 May; 46(5):563-5. PubMed ID: 22550272 [No Abstract] [Full Text] [Related]
13. [Unclear abdominal tumor in pulmonary lymphangioleiomyomatosis]. Braunagel M; Schwarz F; Knösel T; Reiser MF; Graser A Radiologe; 2013 Jan; 53(1):61-4. PubMed ID: 23178789 [No Abstract] [Full Text] [Related]
14. Clinical trial design in hepatocellular carcinoma. Johnson PJ; Billingham LJ Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):119-27. PubMed ID: 15757808 [TBL] [Abstract][Full Text] [Related]
15. What can we learn from phase II adjuvant trials in melanoma? Keilholz U; Suciu S; Eggermont AM Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660 [No Abstract] [Full Text] [Related]
16. Clinical trial design in metastatic breast cancer: a commentary. Levine M Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523 [TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group. Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005 [TBL] [Abstract][Full Text] [Related]
18. [Pulmonary lymphangioleiomyomatosis (clinical picture and therapeutic approach)]. Chuchalin AG; Altunian MP; Bobkov EV Klin Med (Mosk); 1988 Feb; 66(2):55-9. PubMed ID: 3374053 [No Abstract] [Full Text] [Related]
19. Improving the design of phase II trials of cytostatic anticancer agents. Stone A; Wheeler C; Barge A Contemp Clin Trials; 2007 Feb; 28(2):138-45. PubMed ID: 16843736 [TBL] [Abstract][Full Text] [Related]